These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 8532905

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control.
    Corvò R, Giaretti W, Sanguineti G, Geido E, Orecchia R, Barra S, Margarino G, Bacigalupo A, Vitale V.
    Int J Radiat Oncol Biol Phys; 1993 Dec 01; 27(5):1165-72. PubMed ID: 8262843
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks.
    Bourhis J, Dendale R, Hill C, Bosq J, Janot F, Attal P, Fortin A, Marandas P, Schwaab G, Wibault P, Malaise EP, Bobin S, Luboinski B, Eschwege F, Wilson G.
    Int J Radiat Oncol Biol Phys; 1996 Jun 01; 35(3):471-6. PubMed ID: 8655369
    [Abstract] [Full Text] [Related]

  • 6. Lack of predictive value of potential doubling time and iododeoxyuridine labelling index in radiotherapy of squamous cell carcinoma of the head and neck.
    Høyer M, Jørgensen K, Bundgaard T, Johansen LV, Bentzen SM, Overgaard M, Hansen O, Søgaard H, Overgaard J.
    Radiother Oncol; 1998 Feb 01; 46(2):147-55. PubMed ID: 9510042
    [Abstract] [Full Text] [Related]

  • 7. In vivo cell kinetic measurements in a randomized trial of continuous hyperfractionated accelerated radiotherapy with or without mitomycin C in head-and-neck cancer.
    Dobrowsky W, Dobrowsky E, Wilson GD.
    Int J Radiat Oncol Biol Phys; 2003 Mar 01; 55(3):576-82. PubMed ID: 12573744
    [Abstract] [Full Text] [Related]

  • 8. Proliferative characteristics of head and neck tumors. In vivo evaluation by bromodeoxyuridine incorporation and flow cytometry.
    Benazzo M, Mevio E, Occhini A, Franchini G, Danova M.
    ORL J Otorhinolaryngol Relat Spec; 1995 Mar 01; 57(1):39-43. PubMed ID: 7700609
    [Abstract] [Full Text] [Related]

  • 9. Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours.
    Wilson GD, Saunders MI, Dische S, Daley FM, Robinson BM, Martindale CA, Joiner B, Richman PI.
    Cell Prolif; 1996 Mar 01; 29(3):141-52. PubMed ID: 8652743
    [Abstract] [Full Text] [Related]

  • 10. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis.
    Begg AC, Haustermans K, Hart AA, Dische S, Saunders M, Zackrisson B, Gustaffson H, Coucke P, Paschoud N, Hoyer M, Overgaard J, Antognoni P, Richetti A, Bourhis J, Bartelink H, Horiot JC, Corvo R, Giaretti W, Awwad H, Shouman T, Jouffroy T, Maciorowski Z, Dobrowsky W, Struikmans H, Wilson GD.
    Radiother Oncol; 1999 Jan 01; 50(1):13-23. PubMed ID: 10225552
    [Abstract] [Full Text] [Related]

  • 11. Is there a future for cell kinetic measurements using IdUrd or BdUrd?
    Haustermans K, Fowler JF.
    Int J Radiat Oncol Biol Phys; 2001 Feb 01; 49(2):505-11. PubMed ID: 11173147
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tumour growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry.
    Forster G, Cooke TG, Cooke LD, Stanton PD, Bowie G, Stell PM.
    Br J Cancer; 1992 May 01; 65(5):698-702. PubMed ID: 1586597
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The prognostic role of the parameters of cellular kinetics in head and neck tumors treated solely by radiotherapy].
    Corvò R, Giaretti W, Sanguineti G, Geido E, Bacigalupo A, Franzone P, Mereu P, Garaventa G, Barbieri M, Vitale V.
    Radiol Med; 1993 May 01; 86(1-2):135-42. PubMed ID: 8346344
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Proliferative capacity in head and neck cancer.
    Struikmans H, Kal HB, Hordijk GJ, van der Tweel I.
    Head Neck; 2001 Jun 01; 23(6):484-91. PubMed ID: 11360311
    [Abstract] [Full Text] [Related]

  • 20. p53 status of head and neck cancer: relation to biological characteristics and outcome of radiotherapy.
    Wilson GD, Richman PI, Dische S, Saunders MI, Robinson B, Daley FM, Ross DA.
    Br J Cancer; 1995 Jun 01; 71(6):1248-52. PubMed ID: 7779719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.